China Cracks Down On Counterfeit Investment Platforms
China's cyberspace regulator has cracked down on counterfeit investment platforms, Reuters reports.
Agile Therapeutics Announces Pricing of $24M Upsized Public Offering
Agile Therapeutics, Inc. (NASDAQ:AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the pricing of its upsized public offering of an aggregate of
Morgan Stanley Maintains Equal-Weight on Viasat, Lowers Price Target to $34
Morgan Stanley analyst Landon Park maintains Viasat (NASDAQ:VSAT) with a Equal-Weight and lowers the price target from $49 to $34.
Billionaire Beau Wrigley Faces Another Cannabis Lawsuit, This Time Worth $80M, Seeks Arbitration
Billionaire William “Beau” Wrigley Jr, heir to the Wrigley chewing gum fortune, has requested arbitration in a failed Parallel deal to buy six Chicago cannabis companies.
JP Morgan Maintains Overweight on Signature Bank, Lowers Price Target to $300
JP Morgan analyst Steven Alexopoulos maintains Signature Bank (NASDAQ:SBNY) with a Overweight and lowers the price target from $460 to $300.
Morgan Stanley Maintains Equal-Weight on Simply Good Foods, Lowers Price Target to $39
Morgan Stanley analyst Pam Kaufman maintains Simply Good Foods (NASDAQ:SMPL) with a Equal-Weight and lowers the price target from $41 to $39.
Morgan Stanley Maintains Equal-Weight on Haemonetics, Raises Price Target to $70
Morgan Stanley analyst Drew Ranieri maintains Haemonetics (NYSE:HAE) with a Equal-Weight and raises the price target from $60 to $70.
Truist Securities Maintains Buy on Primerica, Lowers Price Target to $150
Truist Securities analyst Mark Hughes maintains Primerica (NYSE:PRI) with a Buy and lowers the price target from $163 to $150.
Morgan Stanley Maintains Underweight on General Mills, Raises Price Target to $66
Morgan Stanley analyst Pamela Kaufman maintains General Mills (NYSE:GIS) with a Underweight and raises the price target from $56 to $66.